T. Rowe Price Associates’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $181M | Sell |
|
|||||
|
2025
Q2 | $173M | Sell |
|
|||||
|
2025
Q1 | $198M | Sell |
|
|||||
|
2024
Q4 | $257M | Buy |
|
|||||
|
2024
Q3 | $241M | Buy |
|
|||||
|
2024
Q2 | $202M | Buy |
|
|||||
|
2024
Q1 | $155M | Buy |
|
|||||
|
2023
Q4 | $133M | Sell |
|
|||||
|
2023
Q3 | $141M | Buy |
|
|||||
|
2023
Q2 | $134M | Sell |
|
|||||
|
2023
Q1 | $109M | Buy |
|
|||||
|
2022
Q4 | $87.7M | Buy |
|
|||||
|
2022
Q3 | $72M | Buy |
|
|||||
|
2022
Q2 | $43.6M | Sell |
|
|||||
|
2022
Q1 | $58.7M | Buy |
|
|||||
|
2021
Q4 | $26.6M | Buy |
|
|||||
|
2021
Q3 | $28.1M | Buy |
|
|||||
|
2021
Q2 | $569K | Buy |
|
|||||
|
2021
Q1 | $728K | Sell |
|
|||||
|
2020
Q4 | $3.67M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $4.21M | Buy |
|
|||||
|
2020
Q1 | $2.09M | Buy |
|